Source:http://linkedlifedata.com/resource/pubmed/id/11843902
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-2-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0141-9854
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
65-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11843902-Doping in Sports,
pubmed-meshheading:11843902-Erythropoietin,
pubmed-meshheading:11843902-Health Policy,
pubmed-meshheading:11843902-Hematocrit,
pubmed-meshheading:11843902-Humans,
pubmed-meshheading:11843902-Male,
pubmed-meshheading:11843902-Predictive Value of Tests,
pubmed-meshheading:11843902-Recombinant Proteins,
pubmed-meshheading:11843902-Reproducibility of Results,
pubmed-meshheading:11843902-Seasons
|
pubmed:year |
2002
|
pubmed:articleTitle |
Haematocrit measurement and antidoping policies.
|
pubmed:publicationType |
Letter
|